Biohaven Pharma to continue late-stage study of Alzheimer's treatment
(Reuters) - Biohaven Pharmaceutical said on Friday it would continue testing its Alzheimer’s disease treatment in a late-stage study as the drug had...
Swiss approve insurance cover for Novartis, Gilead cell therapies
FILE PHOTO: The company's logo is seen at the new cell and gene therapy factory of Swiss drugmaker Novartis in Stein, Switzerland, November...
North Korea to launch medical tourism, targeting visitors from China
SEOUL (Reuters) - North Korea, one of the world’s most reclusive states, plans to branch out into medical tourism next year, offering foreign...
Briton Audrey Schoeman revived after six-hour cardiac arrest
Media playback is...
Biogen builds case for its Alzheimer's drug, skeptics say more data needed
SAN DIEGO/CHICAGO (Reuters) - Biogen Inc on Thursday laid out more data on its experimental Alzheimer’s drug that raised no major safety alarms...
New York doctor convicted of taking kickbacks from opioid maker Insys
NEW YORK (Reuters) - A New York doctor was convicted on Thursday of accepting thousands of dollars in bribes and kickbacks from Insys...
Rural hospital acquisitions may reduce patient services
(Reuters Health) - Although hospitals can improve financially when they join larger health systems, the merger may also reduce access to services for...